Limited Mobile Version
Follow this company and never miss a research update
JAYS

Jays

Market Cap 45.7M

Redeye Research

Today
Day High
1.60
1.53
Day Low
1.37
Day Open
1.60
Prev Close
1.60
VWAP
1.4
Volume
7K
Turnover
0.011M
Top Broker
AVA
VWAP
1.6
Avg Volume
40K
Avg Turnover
0.063M
Top Brokers
AVA/ENS
VWAP
1.6
Avg Volume
42K
Avg Turnover
0.068M
Top Brokers
AVA/NON
VWAP
1.6
Avg Volume
131K
Avg Turnover
0.211M
Top Brokers
AVA/SWB
52 week summary
Price Range
0.9
Last
1.9
Beta
N/A
Market Cap
45.7M
Total Return
-7.0%
Trailing P/E
N/A
Div Yield
N/A%
Shares Outstanding
29.9M
Next Earnings Date
30 Jun
Stock Exchange
First North Stockholm
5 day chart Go to advanced chart

Identify and measure trend strength in stocks with our Momentum tool to identify potential entry and exit signals. The tool provides a set of the most simple but powerful indicators that identify whether a stock is under sell or buy pressure.


Relative Price Strength
Change 3 Months 34.8%
Change 12 Months -29.7%
Volume Trend
Average Volume 10 vs 60 Days -58.0%
Price VS
52 Week High -20.3%
50 Day Moving Average 12.8%
200 Day moving Average 25.8%

Add article markers

Compare Jays to

Prev Close 0 Change 0
High 0 Avg Daily Volume 0
Low 0 Avg Daily Turnover 0
  • Management
  • Rune Torbjörnsen, CEO
  • Executive board
  • Håkan Larsson, Chairman of the board
Source: Millistream
Major Owners Equity Votes
AB Skövde Grönsakshus 23.0%
23.0%
Avanza Pension 9.0%
9.0%
Markus Klasson 7.0%
7.0%
Gunnar Benedikt 7.0%
7.0%
UBS Switzerland AG 4.0%
4.0%
Source: Millistream
  •  
  • Profitability
  • ROE
  • ROCE
  • ROIC
  • EBITDA margin
  • EBIT margin
  • Net margin
  • Per share data (SEK)
  • EPS
  • EPS adj
  • Dividend
  • Net debt
  • Total shares
  • Valuation
  • EV (SEKm)
  • P/E
  • P/E diluted
  • P/Sales
  • EV/Sales
  • EV/EBITDA
  • EV/EBIT
  • P/BV
  • Capital structure
  • Equity ratio
  • Debt/equity ratio
  • Net debt(SEKm)
  • Capital employed(SEKm)
  • Capital turnover rate
  • (SEKm)
  • Net sales
  • Total operating costs
  • EBITDA
  • Depreciation
  • Amortization
  • Impairment charges
  • EBIT
  • Share in profits
  • Net financial items
  • Exchange rate dif.
  • Pre-tax profit
  • Tax
  • Net earnings
  • (SEKm)
  • Assets
  • Current assets
  • Cash in banks
  • Receivables
  • Inventories
  • Other current assets
  • Current assets
  • Fixed assets
  • Tangible assets
  • Associated comp.
  • Investments
  • Goodwill
  • Cap. exp. for dev.
  • O intangible rights
  • O non-current assets
  • Total fixed assets
  • Deferred tax assets
  • Total (assets)
  • Liabilities
  • Current liabilities
  • Short-term debt
  • Accounts payable
  • O current liabilities
  • Current liabilities
  • Long-term debt
  • O long-term liabilities
  • Convertibles
  • Total Liabilities
  • Deferred tax liab
  • Provisions
  • Shareholders' equity
  • Minority interest (BS)
  • Minority & equity
  • Total liab & SE
  • (SEKm)
  • Net sales
  • Total operating costs
  • Depreciations total
  • EBIT
  • Taxes on EBIT
  • NOPLAT
  • Depreciation
  • Gross cash flow
  • Change in WC
  • Gross CAPEX
  • Free cash flow

Estimated Values is behind membership

To access members-only content, you must login or register an account.

Our membership is about gaining access to unique research and knowledge through our analysts and a network of peers. Be the first to get information about news and research in the Nordic life science and technology sectors and use our tools and education to reach your personal and professional goals in investing.

Sign up Login
Source: Redeye
Source: Redeye

Presentations, research interviews and videos from our events listed here.


Source: Redeye

When selecting comparable companies, we try to group companies that are in the same or similar sector or subsector. But, more important, have growth, margins and risk characteristics similar to the company being valued.